These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 33805673)

  • 61. Lack of correlation between immunohistochemical expression of E2F-1, thymidylate synthase expression and clinical response to 5-fluorouracil in advanced colorectal cancer.
    Belvedere O; Puglisi F; Di Loreto C; Cataldi P; Guglielmi A; Aschele C; Sobrero A
    Ann Oncol; 2004 Jan; 15(1):55-8. PubMed ID: 14679120
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Increased cytotoxicity and decreased in vivo toxicity of FdUMP[10] relative to 5-FU.
    Liu J; Skradis A; Kolar C; Kolath J; Anderson J; Lawson T; Talmadge J; Gmeiner WH
    Nucleosides Nucleotides; 1999 Aug; 18(8):1789-802. PubMed ID: 10478484
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Correlations between thymidylate synthase expression and chemosensitivity to 5-fluorouracil, cell proliferation and clinical outcome in head and neck squamous cell carcinoma.
    Yasumatsu R; Nakashima T; Uryu H; Ayada T; Wakasaki T; Kogo R; Masuda M; Fukushima M; Komune S
    Chemotherapy; 2009; 55(1):36-41. PubMed ID: 19023200
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Genomic and tumor biological aspects of the anticancer nicotinamide phosphoribosyltransferase inhibitor FK866 in resistant human colorectal cancer cells.
    Ogino Y; Sato A; Uchiumi F; Tanuma SI
    Genomics; 2019 Dec; 111(6):1889-1895. PubMed ID: 30582964
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Therapeutic enhancement of S-1 with CPT-11 through down-regulation of thymidylate synthase in bladder cancer.
    Ide H; Kikuchi E; Hasegawa M; Hattori S; Yasumizu Y; Miyajima A; Oya M
    Cancer Med; 2013 Aug; 2(4):488-95. PubMed ID: 24156021
    [TBL] [Abstract][Full Text] [Related]  

  • 66. LncRNA ENSG00000254615 Modulates Proliferation and 5-FU Resistance by Regulating p21 and Cyclin D1 in Colorectal Cancer.
    Fu Y; Huang R; Li J; Xie X; Deng Y
    Cancer Invest; 2021 Oct; 39(9):696-710. PubMed ID: 33938344
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Histone deacetylase inhibitor enhances 5-fluorouracil cytotoxicity by down-regulating thymidylate synthase in human cancer cells.
    Lee JH; Park JH; Jung Y; Kim JH; Jong HS; Kim TY; Bang YJ
    Mol Cancer Ther; 2006 Dec; 5(12):3085-95. PubMed ID: 17172411
    [TBL] [Abstract][Full Text] [Related]  

  • 68. B7-H3 increases thymidylate synthase expression via the PI3k-Akt pathway.
    Jiang B; Liu F; Liu Z; Zhang T; Hua D
    Tumour Biol; 2016 Jul; 37(7):9465-72. PubMed ID: 26787540
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Thymidylate synthase O-GlcNAcylation: a molecular mechanism of 5-FU sensitization in colorectal cancer.
    Very N; Hardivillé S; Decourcelle A; Thévenet J; Djouina M; Page A; Vergoten G; Schulz C; Kerr-Conte J; Lefebvre T; Dehennaut V; El Yazidi-Belkoura I
    Oncogene; 2022 Jan; 41(5):745-756. PubMed ID: 34845374
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Thymidylate synthetase (TS) genotype and TS/dihydropyrimidine dehydrogenase mRNA level as an indicator in determining chemosensitivity to 5-fluorouracil in advanced gastric carcinoma.
    Toriumi F; Kubota T; Saikawa Y; Yoshida M; Otani Y; Watanabe M; Kumai K; Kitajima M
    Anticancer Res; 2004; 24(4):2455-63. PubMed ID: 15330198
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Predicting 5-fluorouracil chemosensitivity of liver metastases from colorectal cancer using primary tumor specimens: three-gene expression model predicts clinical response.
    Matsuyama R; Togo S; Shimizu D; Momiyama N; Ishikawa T; Ichikawa Y; Endo I; Kunisaki C; Suzuki H; Hayasizaki Y; Shimada H
    Int J Cancer; 2006 Jul; 119(2):406-13. PubMed ID: 16477629
    [TBL] [Abstract][Full Text] [Related]  

  • 72. MicroRNA-433 negatively regulates the expression of thymidylate synthase (TYMS) responsible for 5-fluorouracil sensitivity in HeLa cells.
    Gotanda K; Hirota T; Matsumoto N; Ieiri I
    BMC Cancer; 2013 Aug; 13():369. PubMed ID: 23915286
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Syndecan-2, negatively regulated by miR-20b-5p, contributes to 5-fluorouracil resistance of colorectal cancer cells via the JNK/ERK signaling pathway.
    Hua R; Zhang Y; Yan X; Tang D; Li X; Ni Q; Wang D; Zhu J
    Acta Biochim Biophys Sin (Shanghai); 2021 Nov; 53(11):1547-1557. PubMed ID: 34596215
    [TBL] [Abstract][Full Text] [Related]  

  • 74. UCN-01 (7-hydroxystaurosporine) enhances 5-fluorouracil cytotoxicity through down-regulation of thymidylate synthetase messenger RNA.
    Abe S; Kubota T; Otani Y; Furukawa T; Watanabe M; Kumai K; Kitajima M
    Jpn J Cancer Res; 2000 Nov; 91(11):1192-8. PubMed ID: 11092986
    [TBL] [Abstract][Full Text] [Related]  

  • 75. CD133+CD24lo defines a 5-Fluorouracil-resistant colon cancer stem cell-like phenotype.
    Paschall AV; Yang D; Lu C; Redd PS; Choi JH; Heaton CM; Lee JR; Nayak-Kapoor A; Liu K
    Oncotarget; 2016 Nov; 7(48):78698-78712. PubMed ID: 27659530
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Single nucleotide polymorphism in the 5' tandem repeat sequences of thymidylate synthase gene predicts for response to fluorouracil-based chemotherapy in advanced colorectal cancer patients.
    Marcuello E; Altés A; del Rio E; César A; Menoyo A; Baiget M
    Int J Cancer; 2004 Dec; 112(5):733-7. PubMed ID: 15386371
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Resveratrol induces chemosensitization to 5-fluorouracil through up-regulation of intercellular junctions, Epithelial-to-mesenchymal transition and apoptosis in colorectal cancer.
    Buhrmann C; Shayan P; Kraehe P; Popper B; Goel A; Shakibaei M
    Biochem Pharmacol; 2015 Nov; 98(1):51-68. PubMed ID: 26310874
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Thymidylate synthase gene amplification in human colon cancer cell lines resistant to 5-fluorouracil.
    Copur S; Aiba K; Drake JC; Allegra CJ; Chu E
    Biochem Pharmacol; 1995 May; 49(10):1419-26. PubMed ID: 7763285
    [TBL] [Abstract][Full Text] [Related]  

  • 79. SPOCK1 silencing decreases 5-FU resistance through PRRX1 in colorectal cancer.
    Qu YL; Liu XL; Zhao SY; Zhai XF
    Pathol Res Pract; 2022 Jun; 234():153895. PubMed ID: 35462225
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Human dihydrofolate reductase and thymidylate synthase form a complex in vitro and co-localize in normal and cancer cells.
    Antosiewicz A; Jarmuła A; Przybylska D; Mosieniak G; Szczepanowska J; Kowalkowska A; Rode W; Cieśla J
    J Biomol Struct Dyn; 2017 May; 35(7):1474-1490. PubMed ID: 27187663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.